Stem Cell Therapy

Funded through a four-year, $8-million grant from the California Institute for Regenerative Medicine, the UCSF Alpha Stem Cell Clinic aims to accelerate the development and delivery of stem cell therapies to patients through high-quality clinical trials.

Dr. Mark Walters is currently leading a phase I study evaluating In Utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses with Alpha Thalassemia Major.